James Zehner
Family Medicine · Pleasantville, PANPI 1851405567
Payments from drug & device makers
Across 111 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$430
- Astellas Pharma US Inc$428
- AstraZeneca$256
- Pfizer$151
- GSK$108
- Amgen$107
- plus $545 from 19 others
What the payments were for
- Food & beverage$1,91294%
- Education$1126%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $430 |
| Astellas Pharma US Inc | 16 | $428 |
| AstraZeneca | 14 | $256 |
| Pfizer | 8 | $151 |
| GSK | 7 | $108 |
| Amgen | 7 | $107 |
| Daiichi Sankyo Inc. | 5 | $76 |
| Merck | 3 | $47 |
| Organogenesis Inc. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 3 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Mylan Specialty L.p. | 2 | $35 |
| Medtronic | 1 | $34 |
| Lilly USA, LLC | 2 | $31 |
| Baxter Healthcare | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Insmed, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
| Braintree Laboratories, Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| AbbVie | 1 | $11 |
| Heraeus Medical, LLC. | 1 | $11 |
| Johnson & Johnson | 1 | $11 |
How this compares
$2,024 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $39,741 |
| EliquisApixaban | 51 | $35,827 |
| Repatha SureclickEvolocumab | 39 | $27,248 |
| JardianceEmpagliflozin | 29 | $22,831 |
| XareltoRivaroxaban | 21 | $18,362 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $13,378 |
| MyrbetriqMirabegron | 13 | $11,517 |
| TrulicityDulaglutide | 12 | $11,474 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $10,261 |
| EntrestoSacubitril/Valsartan | 13 | $8,574 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 40 | $6,172 |
| Tiotropium Bromide | 13 | $5,722 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 30 | $2,836 |
| Metoprolol Succinate | 152 | $2,796 |
| Pravastatin Sodium | 207 | $1,723 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $430 | $39,74143 claims |
| PfizerEliquis | $151 | $35,82751 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $108 | $23,64040 claims |
| Boehringer IngelheimJardiance | $15 | $22,83129 claims |
| Johnson & JohnsonXarelto | $11 | $18,36221 claims |
| Astellas Pharma US IncMyrbetriq | $428 | $11,51713 claims |
| Lilly USA, LLCTrulicity | $31 | $11,47412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Pleasantville
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.